Literature DB >> 18430340

Gastric cancer surgery--a balance of risk and radicality.

Peter Lamb1, T Sivashanmugam, Martin White, Mark Irving, John Wayman, Simon Raimes.   

Abstract

INTRODUCTION: The aim of this study was to determine whether tailoring the extent of resection would allow radical gastric cancer surgery to be performed safely in a UK population. PATIENTS AND METHODS: A total of 180 consecutive patients (median age 70 years; male:female ratio 2:1) undergoing resection for gastric adenocarcinoma with curative intent were studied. Extent of lymphadenectomy was based upon pre-operative and intra-operative staging, and balanced against the patient's age and fitness.
RESULTS: In the study group, 83 patients underwent subtotal or distal partial gastrectomy and 97 patients underwent total or proximal partial gastrectomy. Operative procedures were: D1 lymphadenectomy (n = 62); modified (spleen and pancreas pre-serving) D2 lymphadenectomy (n = 73); D2 lymphadenectomy (n = 42); and extended resection (n = 3). TNM classification was: stage 1 (n = 45); stage 2 (n = 37); stage 3 (n = 61); and stage 4 (n = 37). Of the patients, 48 developed postoperative complications including 17 patients with a major surgical complication. The in-hospital mortality was 1.7% (3 of 180). Predicted mortality according to POSSUM and P-POSSUM was 21.4% and 7.8%, respectively. Disease-specific 5-year survival according to stage was 85.4%, 64.2%, 33.3%, and 6.9%.
CONCLUSIONS: By tailoring the extent of resection and balancing risk and radicality, gastric cancer surgery can be performed with low mortality in Western patients.

Entities:  

Mesh:

Year:  2008        PMID: 18430340      PMCID: PMC2430435          DOI: 10.1308/003588408X261546

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  23 in total

Review 1.  Lymphadenectomy for gastric cancer in clinical trials: update.

Authors:  J D Roder; J J Bonenkamp; J Craven; C J van de Velde; M Sasako; K Böttcher; H J Stein
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

2.  Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.

Authors:  Franco Roviello; Daniele Marrelli; Paolo Morgagni; Giovanni de Manzoni; Alberto Di Leo; Carla Vindigni; Luca Saragoni; Anna Tomezzoli; Hayato Kurihara
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

3.  One-year survey of carcinoma of the oesophagus and stomach in Wales.

Authors:  J K Pye; M K Crumplin; J Charles; R Kerwat; M E Foster; A Biffin
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

4.  Progress in gastric cancer surgery in Japan and its limits of radicality.

Authors:  K Maruyama; K Okabayashi; T Kinoshita
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

7.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Predictors of operative morbidity and mortality in gastric cancer surgery.

Authors:  D J Park; H-J Lee; H-H Kim; H-K Yang; K U Lee; K J Choe
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

9.  Preservation of the spleen improves survival after radical surgery for gastric cancer.

Authors:  J P Griffith; H M Sue-Ling; I Martin; M F Dixon; M J McMahon; A T Axon; D Johnston
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  14 in total

1.  Management and outcome of gastric carcinoma in Zaria, Nigeria.

Authors:  A Ahmed; A Y Ukwenya; J G Makama; I Mohammad
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

2.  Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery.

Authors:  Yoshio Haga; Yasuo Wada; Hitoshi Takeuchi; Koji Ikejiri; Masakazu Ikenaga; Osamu Kimura
Journal:  Gastric Cancer       Date:  2011-05-03       Impact factor: 7.370

3.  Perioperative mortality and morbidity prediction using POSSUM, P-POSSUM and APACHE II in Chinese gastric cancer patients: surgical method is a key independent factor affecting prognosis.

Authors:  Yantian Fang; Chunhsien Wu; Xiaodong Gu; Zhengyang Li; Jianbin Xiang; Zongyou Chen
Journal:  Int J Clin Oncol       Date:  2013-03-09       Impact factor: 3.402

4.  Multivisceral radical en bloc resection with spleen preservation in T4 gastric cancer.

Authors:  Ricardo Cotta-Pereira; Monique Awad; Carlos Eduardo Brandão Mello; Antonio Carlos Garrido Ribeiro Iglesias
Journal:  BMJ Case Rep       Date:  2010-12-06

5.  Preliminary study of surgical audit for overall survival following gastric cancer resection.

Authors:  Yoshio Haga; Koji Ikejiri; Yasuo Wada; Masakazu Ikenaga; Hitoshi Takeuchi
Journal:  Gastric Cancer       Date:  2014-02-06       Impact factor: 7.370

6.  Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Sabrina Ghinassi; Antonio Di Cintio; Leonardo Leone; Luigi Marino Cosentino; Maria Antonietta Viarengo; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2011-03-29

7.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

8.  Comparative Effectiveness of Lymphadenectomy Strategies During Curative Resection for Gastric Adenocarcinoma.

Authors:  Yinin Hu; Timothy L McMurry; Bernadette Goudreau; Katie M Leick; Tri M Le; Victor M Zaydfudim
Journal:  J Gastrointest Surg       Date:  2019-09-12       Impact factor: 3.452

9.  Targeted treatment of liver metastasis from gastric cancer using specific binding peptide.

Authors:  Jianfeng Gong; Gewen Tan; Nengquan Sheng; Weiqiang You; Zhigang Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

10.  Bursectomy in gastric cancer surgery: surgical technique and operative safety.

Authors:  Konstantinos Blouhos; Konstantinos A Boulas; Anestis Hatzigeorgiadis
Journal:  Updates Surg       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.